Evgen Pharma plc AGM statement in full by Barry Clare, Chairman

Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, will hold its Annual General Meeting this afternoon in Manchester. At the AGM, the Company’s Chairman, Barry Clare, will make the following statement:

“The current year is progressing well for our Company. SFX-01, our lead product candidate, continues to be tested in two Phase II trials in different indications, breast cancer and subarachnoid haemorrhage.

“Interest in SFX-01 and sulforaphane-based science continues apace in the academic and translational medicine communities. Earlier this month, we announced that the Manchester Cancer Research Centre will conduct preclinical research of SFX-01 in triple negative breast cancer. Today, we can announce that the Company and the Skeletal Biology Group at the Royal Veterinary College, University of London, has secured grant funding to continue its collaboration and build on earlier encouraging preclinical results demonstrating the potential of SFX-01 as a treatment for osteoarthritis. The RVC will be releasing a separate announcement later today.

“These investigator-led studies underline the broad therapeutic potential of SFX-01 and extend the Company’s commercial presence in sulforaphane-based research. Our primary focus remains on our two Phase II trials and we look forward to making further progress with these trials in the year ahead.”

Dr Stephen Franklin, Evgen Pharma’s CEO, will give a corporate presentation at the AGM. A copy of the presentation is available at the Company’s website, www.evgen.com.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Evgen Pharma Plc

    More articles like this

    Evgen Pharma Plc

    21 Health Benefits of Broccoli

    Are you looking for a vegetable to spice up your diet in a healthy way? If yes, then broccoli, also called Brassica oleracea italica, is the vegetable you want. The dark green crucifer is not only

    Evgen Pharma Plc

    12 things that are actually tied to breast cancer

    According to the Centres for Disease Control and Prevention (CDC), breast cancer is the most common cancer in women. In the US, one in eight women will develop breast cancer during her lifetime. Those statistics sound

    Evgen Pharma Plc

    10 subtle signs of breast cancer

    A diagnosis of breast cancer can be terrifying. According to the CDC, Breast cancer is the most common cancer in American women of any race or ethnicity. Though the statistics might be scary, catching breast cancer

    Evgen Pharma Plc

    Evgen Pharma plc Investor Presentation in Manchester

    Evgen Pharma plc (LON: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces that Steve Franklin, the Company’s CEO, will be presenting tomorrow evening at a ShareSoc Growth

    Evgen Pharma Plc

    ‘I never knew men could get breast cancer’

    Moses Musonga never thought men could get breast cancer until he was diagnosed with the disease in 2013. The 67-year-old Kenyan told the BBC that he was profoundly shock when doctors told him in 2013 that

    Evgen Pharma Plc

    Male Breast cancer:What are the signs and how to check?

    Breast cancer is more commonly associated with women more than with men, affecting approximately one in eight women in their lifetimes. However, men can still be diagnosed with breast cancer, albeit in far rarer circumstances. While